American vanguard corp (AVD)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net income

10,215

13,601

17,568

20,905

23,363

24,062

25,058

22,586

21,553

20,361

15,816

14,639

13,490

13,024

12,087

11,950

9,307

6,317

4,882

2,786

2,018

4,066

2,686

10,823

19,118

33,932

45,102

44,433

44,911

36,826

31,985

28,527

25,790

22,068

0

0

0

Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization of fixed and intangible assets

18,796

18,643

18,550

18,608

18,517

18,891

18,834

18,381

18,003

16,959

16,318

16,062

15,951

16,327

16,651

16,969

16,835

16,474

16,526

16,200

16,553

16,332

15,658

15,380

14,879

14,845

14,755

13,902

13,717

13,487

13,095

13,859

13,764

13,546

0

0

0

Amortization of other long term assets

4,151

4,207

4,428

4,717

4,803

4,884

4,856

4,757

4,961

5,221

5,263

5,622

5,534

5,203

5,218

4,899

4,937

5,275

5,471

5,518

5,787

5,811

5,954

5,823

5,216

4,598

3,840

3,153

3,079

2,925

2,026

1,623

1,412

1,983

0

0

0

Amortization of discounted liabilities

0

-

-

-

-

359

404

299

206

110

8

10

13

16

50

5

100

140

193

303

304

324

293

263

201

174

356

508

662

818

1,327

779

1,181

1,371

0

0

0

Provision for bad debts

360

1,035

1,404

1,480

1,999

1,216

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revision of deferred compensation

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation

7,032

7,160

6,729

6,022

5,981

5,805

5,364

5,170

4,943

4,714

5,096

4,421

3,791

3,167

2,594

2,464

2,910

3,881

4,050

4,832

4,812

4,153

3,970

3,878

3,899

3,819

3,989

3,666

3,216

2,950

2,364

1,994

1,893

1,994

0

0

0

Excess tax benefit from share based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

96

97

63

57

23

45

45

66

300

646

645

618

440

185

518

635

621

0

0

0

-

-

-

-

Decrease in deferred income taxes

2,448

2,616

0

0

0

-

-

-

-

398

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from equity method investment

-198

-209

513

69

-196

-389

-874

-456

-224

-49

-270

-335

-313

-353

0

0

0

-

-

-

-

-983

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net foreign currency adjustment

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from dilution of equity method investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

954

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Changes in assets and liabilities associated with operations:
Decrease (increase) in net receivables

23,667

11,383

13,597

19,992

6,170

22,536

8,427

14,703

20,227

-749

8,361

-13,088

-9,807

11,817

-4

97

779

-13,034

2,648

3,471

-21,080

13,471

-19,660

7,187

-42,319

-2,351

5,294

-4,870

48,113

7,505

8,641

-2,136

35,421

35,021

0

0

0

Increase in inventories

-11,134

-3,817

11,848

18,881

35,645

31,440

20,909

18,505

2,009

-16,183

-18,889

-25,020

-22,473

-15,901

-19,818

-14,132

-22,566

-29,154

-10,024

-10,006

8,522

25,801

44,348

48,090

48,970

51,879

34,357

47,228

34,822

16,883

11,996

-698

-2,630

-2,986

0

0

0

Increase in prepaid expenses and other assets

-1,072

876

-296

951

1,976

-186

-3,366

-2,598

-1,211

-647

6,539

3,869

3,962

3,872

72

722

-2,347

-2,082

-1,637

-449

2,802

4,743

10,406

14,945

15,948

19,733

29,427

31,007

29,184

23,725

9,800

2,587

1,403

1,823

0

0

0

Decrease (increase) in income tax receivable/payable, net

-8,202

-6,855

-3,891

-1,554

3,902

2,655

2,133

408

-13,363

-12,073

-12,470

-12,810

774

1,186

1,652

6,994

6,455

4,872

1,226

3,426

3,351

4,424

0

0

0

-

-

-

4,520

2,137

-1,990

-1,228

2,104

6,512

0

0

0

(Decrease) increase in accounts payable

-12,954

-7,977

-2,130

-12,350

4,272

9,097

4,477

14,052

15,960

3,322

5,646

-243

-7,041

9,015

-153

5,161

4,393

-5,068

5,400

-3,822

-16,000

-19,951

-14,501

263

-23,379

8,252

1,450

581

39,843

9,781

9,185

-37

1,869

8,384

0

0

0

Decrease in deferred revenue

339

-13,355

-367

-6,716

-7,828

5,468

609

5,598

8,380

10,726

-41

-5,234

-3,586

-5,040

3

2,447

2,482

7,990

-981

2,997

3,079

-2,890

626

1,234

-800

-16,639

-908

77

2,279

12,856

1,290

107

-35

2,003

0

0

0

Increase in accrued program costs

9,422

5,797

-4,424

-4,921

-3,948

-1,705

-4,367

-8,309

-6,507

-4,529

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease in other payables and accrued expenses

-2,923

-3,337

-2,518

-2,410

1,319

626

-2,071

-3,268

-1,385

-3,841

-2,029

-1,237

-8,538

4,631

3,435

2,770

4,250

1,952

-19,046

-20,167

-4,533

-4,697

-26,166

-16,307

-13,092

21,958

34,729

31,910

31,299

8,264

17,199

23,215

23,721

10,552

0

0

0

Net cash used in by operating activities

15,720

9,403

4,752

-24,459

318

11,346

25,667

28,603

32,596

59,001

28,450

55,033

53,986

46,406

62,961

60,234

68,316

78,568

51,548

38,768

27,637

-34,095

-47,250

-55,298

-29,968

-6,214

34,523

23,801

29,886

40,424

50,262

73,637

42,173

39,266

0

0

0

Cash flows from investing activities:
Capital expenditures

12,596

12,985

13,442

12,036

9,866

8,050

6,487

5,741

5,139

6,666

9,841

13,056

12,995

10,630

7,825

5,148

6,092

6,899

6,429

6,706

6,886

7,180

8,917

10,854

12,680

15,260

15,010

12,927

16,306

17,628

16,703

17,000

11,069

6,261

0

0

0

Investments

-

-

-

-

-

-

-

-

-

-

-

-

-

3,283

0

0

0

-

-

-

-

-

-

-

-

3,687

0

0

0

-

-

-

-

-

-

-

-

Acquisitions of businesses, product lines and intangible assets

-

41,852

49,849

42,318

43,078

19,647

57,626

70,127

82,411

81,896

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-30,202

-54,837

-63,291

-54,354

-52,944

-27,697

-64,113

-75,868

-88,500

-89,512

-36,695

-27,406

-13,519

-14,137

-11,564

-8,887

-46,167

-43,691

-43,489

-43,766

-7,386

-7,680

-8,917

-10,854

-12,680

-18,947

-22,170

-20,087

-23,466

-21,101

-17,019

-17,316

-11,385

-6,577

0

0

0

Cash flows from financing activities:
Net borrowings under line of credit agreement

18,700

51,900

67,500

26,900

94,575

18,975

115,725

33,925

41,025

37,025

-142,625

-120,775

-120,000

-107,600

-129,280

-156,130

-121,600

-121,400

-14,970

-950

-17,250

44,600

56,250

45,230

92,800

51,550

0

0

0

-

-

-

-

-7,300

0

0

0

Borrowings under line of credit agreement

-

-

-

-

-

-

-

0

160,800

-

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Borrowings on long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Increase in other notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-6,154

255

622

-170

-51

0

0

0

-

-

-

-

Payments on long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

46,000

48,443

50,443

8,943

8,443

7,600

8,425

8,425

8,429

0

0

0

Payment on other long-term liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

704

832

1,101

1,565

1,543

1,637

1,546

1,751

1,756

1,787

1,702

1,505

1,831

0

0

0

-

-

-

-

-

-

-

-

Excess tax benefit from share based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

96

97

63

57

23

45

45

66

300

646

645

618

440

185

518

635

621

0

0

0

-

-

-

-

Net payments from the issuance of common stock (sale of stock under ESPP, exercise of stock options, and shares purchased for tax withholdings)

-1,344

283

-44

-131

357

1,717

1,838

1,836

-206

-713

-783

-778

859

241

267

162

967

317

304

430

-317

1,666

2,297

2,279

2,201

1,610

896

2,469

3,237

3,227

3,266

1,315

447

580

0

0

0

Repurchase of common stock

-

2,604

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,531

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Payment of cash dividends

2,324

2,323

2,329

2,335

2,342

2,199

2,050

1,900

1,749

1,600

0

0

0

-

-

-

-

1,141

2,562

3,977

4,823

5,672

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

14,182

46,406

55,163

77,670

46,826

11,133

38,762

46,910

58,093

33,935

10,967

-25,079

-36,278

-28,545

-49,157

-49,126

-20,033

-32,864

-5,571

7,551

-20,326

41,156

48,576

37,323

40,927

-7,123

-23,565

-19,701

-11,506

-16,429

-13,461

-16,937

-16,576

2,308

0

0

0

Net (decrease) increase in cash and cash equivalents

-300

972

-3,376

-1,143

-5,800

-5,218

316

-355

2,189

3,424

2,722

2,548

4,189

3,724

2,240

2,221

2,116

2,013

2,488

2,553

-75

-619

-7,591

-28,829

-1,721

-32,284

-11,212

-15,987

-5,086

2,894

19,782

39,384

14,212

34,997

0

0

0

Effect of exchange rate changes on cash and cash equivalents

-813

-559

-105

351

-561

49

7

-143

37

44

-271

-750

-1,313

-1,379

-1,075

-1,511

-1,070

-1,374

-2,104

-1,653

-1,446

-1,176

311

604

117

488

-87

353

349

497

10

-1,294

-754

-1,070

0

0

0

Non-cash investing activities:
Deferred consideration in connection with business acquisitions:

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-